LOXL3 expression is thus associated with both primary and metastatic melanomas, and considerably upregulated compared to other LOX family members frequently associated with cancer, such as LOX and LOXL2 [5, 6] (Fig. 1f). Here, LOXL2 is linked to metastatic melanoma.